semaglutide vs tirzepatide weight loss difference ᐅ Optimising Your Mounjaro Journey: A Dietitian's Guide foods to eat while on

Always discuss supplements with your healthcare provider before adding them to your regimen

More serious but less common adverse effects require clinical vigilance: Pancreatitis : Patients should be counselled to stop the medication and seek immediate medical attention if they experience severe, persistent abdominal pain radiating to the back [1] [5] Gallbladder disease : Rapid weight loss associated with GLP-1 therapy may increase cholelithiasis risk [1] Hypoglycaemia : Particularly when used alongside insulin or sulphonylureas in diabetes management Diabetic retinopathy : Semaglutide requires caution in patients with pre-existing retinopathy, who should be monitored regularly [1] Renal impairment : Dehydration from gastrointestinal side effects may affect kidney function Specific considerations for individuals with eating disorders include the potential for GLP-1 medications to exacerbate restrictive eating patterns or mask hunger cues in vulnerable individuals

SURMOUNT and SURMOUNT-OSA: what the tirzepatide trials showed The evidence behind tirzepatide sits within the broader compound class GLP-1 receptor agonists such as semaglutide, liraglutide and dulaglutide, and the GIP/GLP-1 dual agonist tirzepatide itself

,